Bio-pharma Market Report

Europe Bio-pharma Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 18, 2020
  • PAGES：215
  • REPORT CODE：GMM553724
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Bio-pharma market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Bio-pharma Market Segmentations:

    By Player:

    • Biogen Idec

    • Bayer AG

    • Sanofi, Amgen

    • AbbVie

    • Abbott Laboratories

    • Eli Lilly and Company

    • AstraZeneca PLC

    • Bristol-Myers Squibb Company

    • Novartis AG GlaxoSmithKline Plc

    • Johnson & Johnson Services

    • Pfizer

    By Type:

    • Monoclonal Antibodies

    • Recombinant Proteins

    • Granulocyte-Colony Stimulating Factor (G-CSF)

    • Interferons

    • Recombinant Human Insulin

    • Erythropoietin

    • Vaccines

    • Growth Hormones

    • Purified Proteins

    • Others

    By End-User:

    • Metabolic Disorders

    • Oncology

    • Neurological Disorders

    • Cardiovascular Diseases

    • Inflammatory and Infectious Diseases

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Bio-pharma Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Bio-pharma Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    • 1.3.2 Europe Bio-pharma Market Size and Growth Rate of Recombinant Proteins from 2014 to 2026

    • 1.3.3 Europe Bio-pharma Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) from 2014 to 2026

    • 1.3.4 Europe Bio-pharma Market Size and Growth Rate of Interferons from 2014 to 2026

    • 1.3.5 Europe Bio-pharma Market Size and Growth Rate of Recombinant Human Insulin from 2014 to 2026

    • 1.3.6 Europe Bio-pharma Market Size and Growth Rate of Erythropoietin from 2014 to 2026

    • 1.3.7 Europe Bio-pharma Market Size and Growth Rate of Vaccines from 2014 to 2026

    • 1.3.8 Europe Bio-pharma Market Size and Growth Rate of Growth Hormones from 2014 to 2026

    • 1.3.9 Europe Bio-pharma Market Size and Growth Rate of Purified Proteins from 2014 to 2026

    • 1.3.10 Europe Bio-pharma Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Bio-pharma Market Size and Growth Rate of Metabolic Disorders from 2014 to 2026

    • 1.4.2 Europe Bio-pharma Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.3 Europe Bio-pharma Market Size and Growth Rate of Neurological Disorders from 2014 to 2026

    • 1.4.4 Europe Bio-pharma Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • 1.4.5 Europe Bio-pharma Market Size and Growth Rate of Inflammatory and Infectious Diseases from 2014 to 2026

    • 1.4.6 Europe Bio-pharma Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Bio-pharma Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Bio-pharma by Major Types

      • 3.4.1 Market Size and Growth Rate of Monoclonal Antibodies

      • 3.4.2 Market Size and Growth Rate of Recombinant Proteins

      • 3.4.3 Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF)

      • 3.4.4 Market Size and Growth Rate of Interferons

      • 3.4.5 Market Size and Growth Rate of Recombinant Human Insulin

      • 3.4.6 Market Size and Growth Rate of Erythropoietin

      • 3.4.7 Market Size and Growth Rate of Vaccines

      • 3.4.8 Market Size and Growth Rate of Growth Hormones

      • 3.4.9 Market Size and Growth Rate of Purified Proteins

      • 3.4.10 Market Size and Growth Rate of Others

    4 Segmentation of Bio-pharma Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Bio-pharma by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Metabolic Disorders for Construction

      • 4.4.2 Market Size and Growth Rate of Oncology for Construction

      • 4.4.3 Market Size and Growth Rate of Neurological Disorders for Construction

      • 4.4.4 Market Size and Growth Rate of Cardiovascular Diseases for Construction

      • 4.4.5 Market Size and Growth Rate of Inflammatory and Infectious Diseases for Construction

      • 4.4.6 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Bio-pharma Production Analysis by Top Regions

    • 5.2 Europe Bio-pharma Consumption Analysis by Top Regions

    • 5.3 Europe Bio-pharma Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.3 France Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Production, Import, Consumption and Export Analysis

    6 Product Circulation of Bio-pharma Market among Top Countries

    • 6.1 Top 5 Export Countries in Bio-pharma Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Bio-pharma Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Bio-pharma Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Bio-pharma Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Bio-pharma Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Bio-pharma Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Bio-pharma Landscape Analysis

    • 7.1 Germany Bio-pharma Landscape Analysis by Major Types

    • 7.2 Germany Bio-pharma Landscape Analysis by Major End-Users

    8. UK Bio-pharma Landscape Analysis

    • 8.1 UK Bio-pharma Landscape Analysis by Major Types

    • 8.2 UK Bio-pharma Landscape Analysis by Major End-Users

    9. France Bio-pharma Landscape Analysis

    • 9.1 France Bio-pharma Landscape Analysis by Major Types

    • 9.2 France Bio-pharma Landscape Analysis by Major End-Users

    10. Italy Bio-pharma Landscape Analysis

    • 10.1 Italy Bio-pharma Landscape Analysis by Major Types

    • 10.2 Italy Bio-pharma Landscape Analysis by Major End-Users

    11. Spain Bio-pharma Landscape Analysis

    • 11.1 Spain Bio-pharma Landscape Analysis by Major Types

    • 11.2 Spain Bio-pharma Landscape Analysis by Major End-Users

    12. Poland Bio-pharma Landscape Analysis

    • 12.1 Poland Bio-pharma Landscape Analysis by Major Types

    • 12.2 Poland Bio-pharma Landscape Analysis by Major End-Users

    13. Russia Bio-pharma Landscape Analysis

    • 13.1 Russia Bio-pharma Landscape Analysis by Major Types

    • 13.2 Russia Bio-pharma Landscape Analysis by Major End-Users

    14. Switzerland Bio-pharma Landscape Analysis

    • 14.1 Switzerland Bio-pharma Landscape Analysis by Major Types

    • 14.2 Switzerland Bio-pharma Landscape Analysis by Major End-Users

    15. Turkey Bio-pharma Landscape Analysis

    • 15.1 Turkey Bio-pharma Landscape Analysis by Major Types

    • 15.2 Turkey Bio-pharma Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Landscape Analysis by Top Countries

      • 16.3.1 Denmark Bio-pharma Market Volume and Growth Rate

      • 16.3.2 Finland Bio-pharma Market Volume and Growth Rate

      • 16.3.3 Norway Bio-pharma Market Volume and Growth Rate

      • 16.3.4 Sweden Bio-pharma Market Volume and Growth Rate

      • 16.3.6 Iceland Bio-pharma Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Landscape Analysis by Top Countries

      • 17.3.1 Belgium Bio-pharma Market Volume and Growth Rate

      • 17.3.2 Netherlands Bio-pharma Market Volume and Growth Rate

      • 17.3.3 Luxembourg Bio-pharma Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Landscape Analysis by Top Countries

      • 18.3.1 Estonia Bio-pharma Market Volume and Growth Rate

      • 18.3.2 Latvia Bio-pharma Market Volume and Growth Rate

      • 18.3.3 Lithuania Bio-pharma Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Biogen Idec

      • 19.1.1 Biogen Idec Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Bayer AG

      • 19.2.1 Bayer AG Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Sanofi, Amgen

      • 19.3.1 Sanofi, Amgen Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 AbbVie

      • 19.4.1 AbbVie Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Abbott Laboratories

      • 19.5.1 Abbott Laboratories Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Eli Lilly and Company

      • 19.6.1 Eli Lilly and Company Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 AstraZeneca PLC

      • 19.7.1 AstraZeneca PLC Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Bristol-Myers Squibb Company

      • 19.8.1 Bristol-Myers Squibb Company Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Novartis AG GlaxoSmithKline Plc

      • 19.9.1 Novartis AG GlaxoSmithKline Plc Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Johnson & Johnson Services

      • 19.10.1 Johnson & Johnson Services Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Pfizer

      • 19.11.1 Pfizer Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    The List of Tables and Figures (Totals 86 Figures and 149 Tables)

    • Figure Product Picture

    • Figure Bio-pharma Market Size and Growth Rate of Monoclonal Antibodies Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Recombinant Proteins Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Interferons Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Recombinant Human Insulin Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Erythropoietin Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Growth Hormones Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Purified Proteins Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Metabolic Disorders from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Neurological Disorders from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Inflammatory and Infectious Diseases from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure UK Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure France Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Bio-pharma Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Bio-pharma Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Bio-pharma

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Bio-pharma by Different Types from 2014 to 2026

    • Table Consumption Share of Bio-pharma by Different Types from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Monoclonal Antibodies Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Recombinant Proteins Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Interferons Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Recombinant Human Insulin Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Erythropoietin Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Growth Hormones Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Purified Proteins Market, 2015 - 2026 (USD Million)

    • Figure Bio-pharma Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Bio-pharma by Different End-Users from 2014 to 2026

    • Table Consumption Share of Bio-pharma by Different End-Users from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Metabolic Disorders from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Neurological Disorders from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Inflammatory and Infectious Diseases from 2014 to 2026

    • Figure Bio-pharma Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Bio-pharma Production by Major Regions

    • Table Europe Bio-pharma Production Share by Major Regions

    • Figure Europe Bio-pharma Production Share by Major Countries and Regions in 2014

    • Table Europe Bio-pharma Consumption by Major Regions

    • Table Europe Bio-pharma Consumption Share by Major Regions

    • Table Germany Bio-pharma Production, Import, Consumption and Export Analysis

    • Table UK Bio-pharma Production, Import, Consumption and Export Analysis

    • Table France Bio-pharma Production, Import, Consumption and Export Analysis

    • Table Italy Bio-pharma Production, Import, Consumption and Export Analysis

    • Table Spain Bio-pharma Production, Import, Consumption and Export Analysis

    • Table Poland Bio-pharma Production, Import, Consumption and Export Analysis

    • Table Russia Bio-pharma Production, Import, Consumption and Export Analysis

    • Table Switzerland Bio-pharma Production, Import, Consumption and Export Analysis

    • Table Turkey Bio-pharma Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Bio-pharma Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Bio-pharma Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Bio-pharma Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Bio-pharma Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Bio-pharma Consumption by Types from 2014 to 2026

    • Table Germany Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table Germany Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table Germany Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table UK Bio-pharma Consumption by Types from 2014 to 2026

    • Table UK Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table UK Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table UK Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table France Bio-pharma Consumption by Types from 2014 to 2026

    • Table France Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table France Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table France Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table Italy Bio-pharma Consumption by Types from 2014 to 2026

    • Table Italy Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table Italy Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table Italy Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table Spain Bio-pharma Consumption by Types from 2014 to 2026

    • Table Spain Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table Spain Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table Spain Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table Poland Bio-pharma Consumption by Types from 2014 to 2026

    • Table Poland Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table Poland Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table Poland Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table Russia Bio-pharma Consumption by Types from 2014 to 2026

    • Table Russia Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table Russia Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table Russia Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Bio-pharma Consumption by Types from 2014 to 2026

    • Table Switzerland Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table Switzerland Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table Switzerland Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Bio-pharma Consumption by Types from 2014 to 2026

    • Table Turkey Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table Turkey Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table Turkey Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Bio-pharma Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Bio-pharma Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Bio-pharma Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Bio-pharma Market Volume and Growth Rate from 2014 to 2026

    • Table Biogen Idec Profiles

    • Table Biogen Idec Production, Value, Price, Gross Margin 2014-2019

    • Table Biogen Idec Product benchmarking

    • Table Biogen Idec Strategic initiatives

    • Table Biogen Idec SWOT analysis

    • Table Bayer AG Profiles

    • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

    • Table Bayer AG Product benchmarking

    • Table Bayer AG Strategic initiatives

    • Table Bayer AG SWOT analysis

    • Table Sanofi, Amgen Profiles

    • Table Sanofi, Amgen Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi, Amgen Product benchmarking

    • Table Sanofi, Amgen Strategic initiatives

    • Table Sanofi, Amgen SWOT analysis

    • Table AbbVie Profiles

    • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

    • Table AbbVie Product benchmarking

    • Table AbbVie Strategic initiatives

    • Table AbbVie SWOT analysis

    • Table Abbott Laboratories Profiles

    • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Abbott Laboratories Product benchmarking

    • Table Abbott Laboratories Strategic initiatives

    • Table Abbott Laboratories SWOT analysis

    • Table Eli Lilly and Company Profiles

    • Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019

    • Table Eli Lilly and Company Product benchmarking

    • Table Eli Lilly and Company Strategic initiatives

    • Table Eli Lilly and Company SWOT analysis

    • Table AstraZeneca PLC Profiles

    • Table AstraZeneca PLC Production, Value, Price, Gross Margin 2014-2019

    • Table AstraZeneca PLC Product benchmarking

    • Table AstraZeneca PLC Strategic initiatives

    • Table AstraZeneca PLC SWOT analysis

    • Table Bristol-Myers Squibb Company Profiles

    • Table Bristol-Myers Squibb Company Production, Value, Price, Gross Margin 2014-2019

    • Table Bristol-Myers Squibb Company Product benchmarking

    • Table Bristol-Myers Squibb Company Strategic initiatives

    • Table Bristol-Myers Squibb Company SWOT analysis

    • Table Novartis AG GlaxoSmithKline Plc Profiles

    • Table Novartis AG GlaxoSmithKline Plc Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis AG GlaxoSmithKline Plc Product benchmarking

    • Table Novartis AG GlaxoSmithKline Plc Strategic initiatives

    • Table Novartis AG GlaxoSmithKline Plc SWOT analysis

    • Table Johnson & Johnson Services Profiles

    • Table Johnson & Johnson Services Production, Value, Price, Gross Margin 2014-2019

    • Table Johnson & Johnson Services Product benchmarking

    • Table Johnson & Johnson Services Strategic initiatives

    • Table Johnson & Johnson Services SWOT analysis

    • Table Pfizer Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Pfizer Product benchmarking

    • Table Pfizer Strategic initiatives

    • Table Pfizer SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US